Baird analyst David Rescott raised the firm’s price target on iRhythm (IRTC) to $235 from $220 and keeps an Outperform rating on the shares. The firm updated its model following results where the company continue to impress on year-to-date acceleration and positive catalysts are ahead.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRTC:
- iRhythm price target raised to $215 from $195 at BTIG
- iRhythm price target raised to $242 from $205 at Citi
- iRhythm price target raised to $212 from $193 at Canaccord
- Irhythm Technologies: Strong Q3 Performance and Positive Outlook Justify Buy Rating
- Irhythm Technologies: Strong Performance and Promising Growth Potential Justify Buy Rating